Dashboard
Manage Tickers

CMND Clearmind Medicine Inc.

Nasdaq clearmindmedicine.com


$ 0.58 $ -0.04 (-5.24 %)    

Thursday, 06-Nov-2025 19:50:36 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 613.36 $ -9.99 (-1.61 %)
DIA $ 470.23 $ -2.78 (-0.59 %)
SPY $ 671.96 $ -6.30 (-0.93 %)
TLT $ 89.61 $ 0.21 (0.23 %)
GLD $ 367.27 $ -1.11 (-0.3 %)
$ 0.7413
$ 0.78
$ 0.55 x 73
$ 0.82 x 2
$ 0.72 - $ 0.79
$ 0.72 - $ 2.18
357,040
na
nm
$ 0.29
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

clearmind-medicine-receives-nasdaq-delisting-notification
Clearmind Medicine Receives Nasdaq Delisti...
11/06/2025 21:26:38

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech co...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
11/06/2025 21:06:30

clearmind-expands-meai-patent-protection-with-new-south-korea-filing-advancing-global-depression-treatment-strategy
Clearmind Expands MEAI Patent Protection W...
11/05/2025 11:57:41

Patent expands MEAI's global intellectual property protection as Clearmind advances clinical development and commercializat...

clearmind-medicine-publishes-us-patent-application-for-non-hallucinogenic-meai-to-treat-cocaine-addiction-strengthening-intellectual-property-portfolio
Clearmind Medicine Publishes U.S. Patent A...
10/31/2025 11:37:51

clearmind-medicine-says-last-patient-of-first-cohort-in-phase-iiia-clinical-trial-evaluating-cmnd-100-receives-treatment-fda-approved-clinical-protocol
Clearmind Medicine Says Last Patient Of Fi...
10/30/2025 11:59:44

Milestone advances MEAI-based therapy targeting a global Alcohol Use Disorder treatment market projected to surpass $20 billion...

clearmind-medicine-enrolls-last-patient-for-first-cohort-of-phase-iiia-clinical-trial-evaluating-cmnd-100-proprietary-meai-based-oral-drug-candidate-for-aud-treatment
Clearmind Medicine Enrolls Last Patient Fo...
10/21/2025 11:26:42

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech com...

Core News & Articles
SciSparc And Clearmind File US Patent For ...
10/20/2025 11:45:47

SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusi...

Core News & Articles
Clearmind Medicine Files US Patent For Psy...
10/20/2025 11:43:38

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech com...

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
09/22/2025 12:09:30

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
09/19/2025 21:06:05

clearmind-medicine-enters-10m-convertible-note-agreement-with-institutional-investors-begins-with-555k-issuance-at-500k-purchase-price
Clearmind Medicine Enters $10M Convertible...
09/19/2025 12:21:40

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech com...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/28/2025 21:06:27

Core News & Articles
Clearmind Medicine Publishes International...
08/07/2025 11:39:10

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech com...

clearmind-medicine-receives-irb-approval-from-hadassah-medical-center-jerusalem-for-ongoing-phase-12a-clinical-trial-evaluating-cmnd-100-proprietary-meai-based-oral-drug-candidate-for-treatment-of-aud
Clearmind Medicine Receives IRB Approval F...
08/05/2025 12:22:29

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech com...

Core News & Articles
SciSparc And Clearmind File International ...
07/30/2025 12:13:34

SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusi...

clearmind-medicine-completes-site-initiation-at-tel-aviv-sourasky-medical-center-for-phase-iiia-clinical-trial-evaluating-cmnd-100-proprietary-oral-drug-candidate-for-aud
Clearmind Medicine Completes Site Initiati...
07/23/2025 12:56:53

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech com...

clearmind-expands-phase-iiia-clinical-trial-for-cmnd-100-with-activation-of-additional-site-at-johns-hopkins-university-school-of-medicine-and-enrollment-of-first-participant-at-clinical-site
Clearmind Expands Phase I/IIa Clinical Tri...
07/15/2025 12:13:54

clearmind-medicine-granted-us-patent-12350242-for-binge-behavior-regulators
Clearmind Medicine Granted U.S. Patent #12...
07/08/2025 20:00:49

https://ppubs.uspto.gov/api/pdf/downloadPdf/12350242?requestToken=eyJzdWIiOiJlMmEyMTIwZi01YWZmLTQ5NGMtYjFkYi1lZTVmMmQ3MzM4NDgiL...

clearmind-medicine-receives-irb-approval-from-tasmc-in-tel-aviv-for-ongoing-phase-12a-clinical-trial-evaluating-cmnd-100-for-aud-treatment
Clearmind Medicine Receives IRB Approval F...
07/03/2025 12:48:37

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech com...

clearmind-doses-first-patient-in-phase-iiia-trial-of-psychedelic-based-cmnd-100-for-alcohol-use-disorder
Clearmind Doses First Patient In Phase I/I...
06/30/2025 13:22:40

Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech com...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION